Clinical Trials Directory

Trials / Unknown

UnknownNCT05003336

Effects of Xiangshao Granules on Anxiety in Menopausal Women.

Effects of Xiangshao Granules on Anxiety in Menopausal Women: A Multicenter, Randomized, Double-blind, Placebo-controlled Study.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
360 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
Female
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Symptoms of anxiety are prevalent during the menopausal transition and early postmenopause. These symptoms are mainly improved by anti-anxiety agents, which are associated with some adverse effects including dizziness, sleepiness, and constipation and not all patients respond to currently available pharmacological treatments, thus novel agents with fewer side effects are needed. Some studies have shown that traditional Chinese medicine can alleviate menopausal symptoms safely and economically, and improve quality of life. Xiangshao granules reportedly have good curative effects on menopausal symptoms and premenstrual syndrome and exhibit good safety. This study aim to evaluate the efficacy and safety of Xiangshao granule in improving anxiety state of women with menopause syndrome.

Conditions

Interventions

TypeNameDescription
DRUGXiangshao Granulesdissolve 1 sachet (4 g) in water to be drank 3 times a day after meal for 8 weeks
DRUGXiangshao Granules PlaceboXiangshao Granules Placebo

Timeline

Start date
2021-12-23
Primary completion
2023-03-01
Completion
2023-06-01
First posted
2021-08-12
Last updated
2022-12-27

Locations

18 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05003336. Inclusion in this directory is not an endorsement.